Calidi Biotherapeutics Provides Required NYSE American Disclosure
May 22, 2026 18:00 ET | Source: Calidi Biotherapeutics, Inc SAN DIEGO,…
Regeneron Provides Update on Phase 3 Trial of Fianlimab (LAG-3 Inhibitor) Combination in First-Line Unresectable or Metastatic Melanoma
May 15, 2026 20:19 ET | Source: Regeneron Pharmaceuticals, Inc. The trial…
GLG Provides Expert Insights on Bloomberg’s ASKB
GLG and Bloomberg Terminal® clients can now access the premium research provider's…
Sankaty Jet Capital Provides $68 Million Debt Facility to Wheels Up
Sankaty Jet Capital, a wholly owned subsidiary of AIP Capital, has committed…
ZyVersa Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
ZyVersa is advancing a highly differentiated pipeline focusing on inflammatory and renal…
uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates
~ Advancing FDA interactions on AMT-130 for Huntington’s disease; Type B meeting…
Nicox Provides Full Year 2025 Financial Results and Corporate Update
April 30, 2026 01:30 ET | Source: NICOX SA Press Release Nicox…
CORRECTION — Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs
Company Planning Multi-Pronged Approach for QRX009 Including Several Investigator Led Clinical Studies…
Oncotelic Therapeutics Provides Corporate Update on Partnership Strategy
AGOURA HILLS, Calif., April 24, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc.…
Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update
– Released positive topline data from Phase 1 study of IV rademikibart…
